Search

Author/Creator Gozman, Alexander

1. 318 Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation and/or homologous recombination repair deficiency: KEYLYNK-007. (9th November 2020)

Authors:
Yap, Timothy A; Dhawan, Mallika; Hendifar, Andrew E; Maio, Michele; Owonikoko, Taofeek K; Quintela-Fandino, Miguel; Shapira-Frommer, Ronnie; Saraf, Sanatan; Qiu, Ping; Jin, Fan; Gozman, Alexander; Levine, Douglas A
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A344
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 318 Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation and/or homologous recombination repair deficiency: KEYLYNK-007. (10th December 2020)

Authors:
Yap, Timothy A; Dhawan, Mallika; Hendifar, Andrew E; Maio, Michele; Owonikoko, Taofeek K; Quintela-Fandino, Miguel; Shapira-Frommer, Ronnie; Saraf, Sanatan; Qiu, Ping; Jin, Fan; Gozman, Alexander; Levine, Douglas A
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CTIM-03. PEMBROLIZUMAB MONOTHERAPY FOR MICROSATELLITE INSTABILITY-HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) RECURRENT GLIOMAS: RESULTS FROM THE MULTICOHORT PHASE 2 KEYNOTE-158 STUDY. (14th November 2022)

Authors:
Baldini, Capucine; Cassier, Philippe A; Delord, Jean-Pierre; Simonelli, Matteo; Touat, Mehdi; Yao, Lili; Duic, J Paul; Gozman, Alexander; Marabelle, Aurelien
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗